As a leading 1'-(2-Methylalanyl-O-Benzyl-D-Seryl)-1-(Methylsulfonyl)-1,2-Dihydrospiro[Indole-3,4'-Piperidine] Methanesulfonate supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
1 '- (2 - Methylalanyl - O - Benzyl - D - Seryl) - 1 - (Methylsulfonyl) - 1,2 - Dihydrospiro [Indole - 3,4' -Piperidine] What is the chemical structure of Methanesulfonate?
The name of this organic compound is complicated and verbose, and it is not easy to know its chemical structure. However, I should try my best to solve your confusion.
Consider its name "1% 27 - +% 282 + - + Methyl alanyl + - + O + - + Benzyl + - + D + - + Se ryl% 29 + - + 1 + - + + - + 1% 2C2 + - + Dihydrospiro%5BIndole + - + 3% 2C4% 27 - Piperidine% 5D + Methanesulfonate", which can be gradually analyzed.
Where "1,2 - Dihydrospiro [Indole - 3,4 '- Piperidine]", this is the key structural part, showing the state of a spiral ring, the indole ring and the piperidine ring are connected by a spiral atom, forming a unique spatial structure at a specific position. "Methylsulfonyl" is a methylsulfonyl group with double bonds of sulfur and oxygen and methyl groups, which is attached to the main structure, affecting its electron cloud distribution and chemical activity.
Furthermore, " (2 - Methylalanyl - O - Benzyl - D - Seryl) ", this fragment is derived from amino acids. Methylalanyl is a methylalanyl group containing methyl-modified alanine residues; O-Benzyl indicates that benzyl is attached to an oxygen atom; D-Seryl is a D-seramyl group. These amino acid residues are connected by peptide bonds to form specific sequences, giving the compound unique chemical and biological properties.
Finally, "Methanesulfonate" is a methanesulfonate ion, which binds to the main structure and often exists in the form of salts, which affects the solubility and stability of the compound.
Although the chemical structure is very complex, it can also be seen through the stripping of the cocoon.
1 '- (2 - Methylalanyl - O - Benzyl - D - Seryl) - 1 - (Methylsulfonyl) - 1,2 - Dihydrospiro [Indole - 3,4' -Piperidine] What is the main use of Methanesulfonate?
1% 27- (2-methylalanyl-O-benzyl-D-seranyl) -1- (methylsulfonyl) -1,2-dihydrospiro [indole-3,4 '-piperidine] methanesulfonate, which is mostly used in the field of medicine and chemical industry. Its main uses are often involved in drug research and development. When creating new drugs, it is used as a key active ingredient, with its unique chemical structure and characteristics, or it can act on specific biological targets, intervene in physiological and pathological processes, and achieve the purpose of treating diseases.
For example, in some disease-specific drug screening and design, this compound can precisely fit with disease-related receptors because of its structure, thereby regulating biological signaling pathways, or may become a potential active ingredient in the treatment of difficult diseases. In pharmaceutical chemistry research, researchers analyze its interaction mode with biomacromolecules, optimize drug structure, improve drug efficacy, reduce toxic and side effects, and promote the development of new drugs. This compound plays an important role in the frontier exploration of medical research, providing new opportunities and directions for solving various disease problems, and is of great significance to the development of medicine.
1 '- (2 - Methylalanyl - O - Benzyl - D - Seryl) - 1 - (Methylsulfonyl) - 1,2 - Dihydrospiro [Indole - 3,4' -Piperidine] What are the safety and side effects of Methanesulfonate?
1% 27- (2 - Methylalanyl - O - Benzyl - D - Seryl) -1- (Methylsulfonyl) -1,2 - Dihydrospiro [Indole - 3,4 '-Piperidine] Methanesulfonate, which is a relatively complex organic compound. However, regarding its safety and side effects, due to the lack of accurate records in relevant books, it can only be speculated from similar compounds and modern studies.
In terms of safety, such organic compounds with complex structures may have latent risks. Specific groups in their structures, such as methylsulfonyl groups, are in some similar compounds, or affect the human metabolic system. After entering the human body, or through a series of biochemical reactions, it interferes with normal cell metabolism, affects intracellular signal transduction pathways, and thus adversely affects cell function. And this compound contains a spiro ring structure, and its unique spatial configuration may affect the binding characteristics of molecules and biological macromolecules. Although it can enhance the affinity with specific targets, it may also increase the probability of non-specific binding, which may affect normal physiological functions.
Discussing its side effects, from the perspective of similar compounds containing indole and piperidine structures, it may affect the nervous system. For example, some drugs containing indole structure can cause symptoms such as dizziness and drowsiness. It is speculated that this compound may also affect the transmission of neurotransmitters and interfere with the normal function of the nervous system. At the same time, because it contains methanesulfonate ions, it may change the acid-base balance in the body, affect electrolyte metabolism, and cause gastrointestinal discomfort, such as nausea, vomiting and other symptoms. In addition, complex structures may cause slow metabolism in the body, drug accumulation, and increase the risk of adverse reactions.
Although the above is mostly based on similar compounds, it is necessary to pay close attention to the safety and side effects of such complex compounds in clinical use and research. After a large number of experiments and clinical observations, its related properties can be clearly clarified.
1 '- (2 - Methylalanyl - O - Benzyl - D - Seryl) - 1 - (Methylsulfonyl) - 1,2 - Dihydrospiro [Indole - 3,4' -Piperidine] Methanesulfonate is used in what fields?
This is 1% 27 - (2-methylalanyl-O-benzyl-D-seranyl) - 1 - (methylsulfonyl) - 1,2-dihydrospiro [indole-3,4 '-piperidine] methanesulfonate, this compound is used in the field of medicine, or has miraculous uses. To cover the way of medicine, if you want to eliminate diseases and diseases, you must rely on the properties of various compounds. This agent may be used in the treatment and prevention of diseases.
In the process of observing the development of drugs, new compounds are often explored, hoping that they can target the mechanism of diseases. The unique structure of this compound may enable it to bind specifically with biological macromolecules in vivo to regulate physiological processes. For some difficult and miscellaneous diseases, such as specific tumors and neurodegenerative diseases, it may be able to reverse the disease by leveraging the action of key targets.
Furthermore, in the field of organic synthesis, the synthesis of this compound can also be a challenge and an opportunity. The art of synthesis requires careful study of the steps, consideration of reaction conditions and raw material selection, in order to achieve efficient preparation. If this complex structure can be successfully synthesized, it can also add to the organic synthesis technology and provide valuable experience and ideas for the creation of subsequent related compounds.
In the field of drug analysis, the analysis of its purity, stability and other properties is related to whether it can be used as a medicine. Accurate analysis can provide insight into its quality and lay a solid foundation for its application.
In summary, this compound may contain important value in the fields of pharmaceutical research and development, organic synthesis, drug analysis, etc., and we need to explore it in depth to understand its true meaning and benefit the common people.
1 '- (2 - Methylalanyl - O - Benzyl - D - Seryl) - 1 - (Methylsulfonyl) - 1,2 - Dihydrospiro [Indole - 3,4' -Piperidine] Methanesulfonate What is the synthesis method?
To prepare 1% 27- (2-methylalanyl-O-benzyl-D-serinyl) -1- (methylsulfonyl) -1,2-dihydrospiro [indole-3,4 '-piperidine] methanesulfonate, the method is as follows:
First take an appropriate amount of raw material containing indole structure, put it in a suitable reaction vessel, protect it with an inert gas such as nitrogen, add an appropriate amount of organic solvent, and fully dissolve the raw material. The selected organic solvent needs to be free of interference to the reaction system and can dissolve the raw material well, such as dichloromethane, N, N-dimethylformamide and the like.
Then, a specific reagent is added to it to introduce the methylsulfonyl group. This process requires precise control of the reaction temperature and time, and the temperature may be maintained in the low temperature range, such as 0 ° C to 5 ° C, for about several hours. According to the reaction process, thin layer chromatography and other monitoring methods are used until the raw material is completely converted.
Then, a fragment containing 2-methylalanyl-O-benzyl-D-serinyl structure is prepared. The corresponding amino acid raw materials are taken, and the fragment is constructed after a series of reactions such as protection and condensation. The selection of protective groups is very critical, which needs to be able to effectively protect specific functional groups and be easy to remove later. The condensation reaction can be selected with a suitable condensation agent, such as dicyclohexyl carbodiimide (DCC) with 4-dimethylaminopyridine (DMAP), etc., at a suitable temperature and time to react, so that the amino acid fragments are successfully connected.
After the above fragment is prepared, it is mixed with the indole derivative containing methylsulfonyl group before, and the reaction is carried out under suitable conditions to construct the spiro [indole-3,4 '-piperidine] structure. This step may require the participation of specific catalysts, and the reaction temperature and time also need to be finely adjusted, or the reaction progress can be monitored in real time between room temperature and 50 ° C, and the reaction time can range from several hours to ten hours.
Finally, when the main structure of the target product is formed, a salt-forming reaction is carried out. Methanesulfonic acid is slowly added to the reaction system to control the reaction conditions and convert the product into methanesulfonate form. After that, through separation and purification steps, such as column chromatography, recrystallization, etc., high-purity 1% 27- (2-methylalanyl-O-benzyl-D-seranyl) -1- (methylsulfonyl) -1,2-dihydrospiro [indole-3,4 '-piperidine] methanesulfonate is obtained.